GetTopicDetailResponse(id=a71d16e316, topicName=Aalectinib, introduction=Aalectinib, content=null, image=null, comments=2, allHits=649, url=https://h5.medsci.cn/topic?id=1673, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=38866, tagList=[TagDto(tagId=38866, tagName=Aalectinib)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1779279, encodeId=6c751e7927999, content=<a href='/topic/show?id=a71d16e316' target=_blank style='color:#2F92EE;'>#Aalectinib#</a>, objectTitle=ALK陽(yáng)性NSCLC治療藥物Aalectinib被FDA授予突破性藥物資格, objectType=article, longId=79315, objectId=590ee9315c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=590ee9315c5, replyNumber=0, likeNumber=92, createdTime=2017-08-08, rootId=0, userName=gous, userId=7a9987, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=590ee9315c5, moduleTitle=ALK陽(yáng)性NSCLC治療藥物Aalectinib被FDA授予突破性藥物資格, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=590ee9315c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1778903, encodeId=07ea1e78903d3, content=<a href='/topic/show?id=a71d16e316' target=_blank style='color:#2F92EE;'>#Aalectinib#</a>, objectTitle=ALK陽(yáng)性NSCLC治療藥物Aalectinib被FDA授予突破性藥物資格, objectType=article, longId=79315, objectId=590ee9315c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=590ee9315c5, replyNumber=0, likeNumber=85, createdTime=2017-04-15, rootId=0, userName=gous, userId=7a9987, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=590ee9315c5, moduleTitle=ALK陽(yáng)性NSCLC治療藥物Aalectinib被FDA授予突破性藥物資格, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=590ee9315c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
